Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Heitjan

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Statistics in Medicine|July 19, 2012
Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trialTao Liu, Daniel F Heitjan
Pharmaceutical Statistics|March 23, 2007
Weibull prediction of event times in clinical trialsGui-shuang Ying, Daniel F Heitjan
Clinical Trials (London, England)|January 17, 2013
Prediction of event times in the REMATCH TrialGui-Shuang Ying, Daniel F Heitjan
Statistics in Medicine|November 10, 2018
Statistical modeling and prediction of clinical trial recruitmentYu Lan, Gong Tang, Daniel F Heitjan
Clinical Trials (London, England)|January 9, 2015
Suspension of accrual in phase II cancer clinical trialsYimei Li, Rosemarie Mick, Daniel F Heitjan
Respiratory Care|March 26, 2024
Predicting Hospital Readmission in Medicaid Patients With COPD Using Administrative and Claims DataDaniel F Heitjan, Yifei Wang, Jaehyeon Yun
Clinical Trials (London, England)|April 24, 2012
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trialsYimei Li, Rosemarie Mick, Daniel F Heitjan
Journal of the American Medical Informatics Association : JAMIA|April 25, 2002
Design and analysis of controlled trials in naturally clustered environments: implications for medical informaticsJen-Hsiang Chuang, George Hripcsak, Daniel F Heitjan
Statistics in Medicine|April 15, 2004
Bayesian estimation of cost-effectiveness from censored dataDaniel F Heitjan, Clara Yuri Kim, Huiling Li
Statistics in Medicine|January 16, 2010
Modeling smoking cessation data with alternating states and a cure fraction using frailty modelsYimei Li, E Paul Wileyto, Daniel F Heitjan
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Statistics in Medicine|July 19, 2012
Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trialTao Liu, Daniel F Heitjan
Pharmaceutical Statistics|March 23, 2007
Weibull prediction of event times in clinical trialsGui-shuang Ying, Daniel F Heitjan
Clinical Trials (London, England)|January 17, 2013
Prediction of event times in the REMATCH TrialGui-Shuang Ying, Daniel F Heitjan
Statistics in Medicine|November 10, 2018
Statistical modeling and prediction of clinical trial recruitmentYu Lan, Gong Tang, Daniel F Heitjan
Clinical Trials (London, England)|January 9, 2015
Suspension of accrual in phase II cancer clinical trialsYimei Li, Rosemarie Mick, Daniel F Heitjan
Respiratory Care|March 26, 2024
Predicting Hospital Readmission in Medicaid Patients With COPD Using Administrative and Claims DataDaniel F Heitjan, Yifei Wang, Jaehyeon Yun
Clinical Trials (London, England)|April 24, 2012
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trialsYimei Li, Rosemarie Mick, Daniel F Heitjan
Journal of the American Medical Informatics Association : JAMIA|April 25, 2002
Design and analysis of controlled trials in naturally clustered environments: implications for medical informaticsJen-Hsiang Chuang, George Hripcsak, Daniel F Heitjan
Statistics in Medicine|April 15, 2004
Bayesian estimation of cost-effectiveness from censored dataDaniel F Heitjan, Clara Yuri Kim, Huiling Li
Statistics in Medicine|January 16, 2010
Modeling smoking cessation data with alternating states and a cure fraction using frailty modelsYimei Li, E Paul Wileyto, Daniel F Heitjan
Pageof 13